Rheumatology NewsNew recommendations tout biosimilars for rheumatologic diseasesSeptember 7, 2017SpondyloarthropathiesRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitis
Rheumatology NewsFDA approves second adalimumab biosimilar for multiple conditionsAugust 28, 2017Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPediatricsPsoriatic Arthritis
Rheumatology NewsNoninvasive NASH test could help monitor hepatotoxicity in patients on methotrexateAugust 24, 2017Psoriatic Arthritis
Rheumatology NewsMusculoskeletal ultrasound training now offered in nearly all U.S. rheumatology fellowshipsAugust 23, 2017Rheumatoid ArthritisPsoriatic ArthritisPediatricsGout
Rheumatology NewsStudy shows more changes, less stopping of PsA systemic drugsAugust 17, 2017Psoriatic Arthritis
Rheumatology NewsPsoriasis, psoriatic arthritis research makes headway at GRAPPA meetingAugust 10, 2017Psoriatic Arthritis
Rheumatology NewsStudy finds secukinumab effective for moderate to severe scalp psoriasisAugust 9, 2017Psoriatic Arthritis
Rheumatology NewsFDA committee recommends approval of tofacitinib for PsAAugust 3, 2017Psoriatic Arthritis
Rheumatology NewsFirst interchangeability study for an adalimumab biosimilar has begunJuly 31, 2017Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsChildren with psoriasis face multitude of comorbiditiesJuly 15, 2017PediatricsPsoriatic Arthritis
Rheumatology NewsFirst IL-23 blocker, guselkumab, earns FDA approval for psoriasisJuly 13, 2017Psoriatic Arthritis
Rheumatology NewsComorbidities in psoriatic arthritis flag worse prognosisJuly 8, 2017Psoriatic Arthritis
Rheumatology NewsFDA approves abatacept for adults with psoriatic arthritisJuly 7, 2017Psoriatic Arthritis
